Richard Gallagher | Apr 25, 2004 | 3 min read
I recently listened to a panel discussion on the future of biomedical science. The standout participant, an urbane and knowledgeable contributor, was the CEO of a major pharmaceutical company. He won the audience over with his optimistic vision for the future of drug development, his conviction of the necessity of collaboration between academia and industry, and his characterization of the high ethical standards that his company and the industry in general have met.My interest piqued by this and